AU586649B2 - Halogenohydroxyflavones - Google Patents

Halogenohydroxyflavones

Info

Publication number
AU586649B2
AU586649B2 AU49888/85A AU4988885A AU586649B2 AU 586649 B2 AU586649 B2 AU 586649B2 AU 49888/85 A AU49888/85 A AU 49888/85A AU 4988885 A AU4988885 A AU 4988885A AU 586649 B2 AU586649 B2 AU 586649B2
Authority
AU
Australia
Prior art keywords
halogenohydroxyflavones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU49888/85A
Other languages
English (en)
Other versions
AU4988885A (en
Inventor
Prof. Dr. Rolf-Dieter Hesch
Dr. Klaus Irmscher
Dr. Josef Kramer
Helmut Prucher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU4988885A publication Critical patent/AU4988885A/en
Application granted granted Critical
Publication of AU586649B2 publication Critical patent/AU586649B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
AU49888/85A 1984-11-26 1985-11-12 Halogenohydroxyflavones Ceased AU586649B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3443007 1984-11-26
DE3443007 1984-11-26
DE19853505611 DE3505611A1 (de) 1984-11-26 1985-02-19 Halogen-hydroxy-flavone
DE3505611 1985-02-19

Publications (2)

Publication Number Publication Date
AU4988885A AU4988885A (en) 1986-06-05
AU586649B2 true AU586649B2 (en) 1989-07-20

Family

ID=25826817

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49888/85A Ceased AU586649B2 (en) 1984-11-26 1985-11-12 Halogenohydroxyflavones

Country Status (7)

Country Link
US (2) US4713465A (hu)
EP (1) EP0183169B1 (hu)
JP (1) JPH0749427B2 (hu)
AU (1) AU586649B2 (hu)
DE (2) DE3505611A1 (hu)
ES (1) ES8708220A1 (hu)
HU (1) HU194856B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
DE4011187A1 (de) * 1990-04-06 1991-10-10 Hoechst Ag Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte
DE69333611T2 (de) * 1992-12-21 2005-09-15 Mallinckrodt, Inc. Radiomarkierte mehrwertige phenolverbindungen
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
PL179170B1 (pl) * 1995-09-15 2000-07-31 Inst Lekow Nowe zwiazki,pochodne genisteiny PL PL PL PL
AUPQ008299A0 (en) * 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
DE10242045B4 (de) * 2002-09-11 2014-03-20 Valmet Automotive Oy Cabriolet-Fahrzeug
US7373991B2 (en) * 2005-07-18 2008-05-20 Schlumberger Technology Corporation Swellable elastomer-based apparatus, oilfield elements comprising same, and methods of using same in oilfield applications
US9120744B2 (en) * 2007-04-16 2015-09-01 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
DE102011080517A1 (de) 2011-08-05 2013-02-07 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Messaufnehmer zur Bestimmung einer eine Aktivität eines Ziel-Ions in einem Messmedium repräsentierenden Messgröße

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5715780A (en) * 1979-04-10 1980-10-16 F. Hoffmann-La Roche & Co. 3-alkoxy flavone derivatives
AU2087083A (en) * 1982-11-02 1984-05-10 Hokuriku Pharmaceutical Co. Ltd. N-substituted flavone 8-carboxamides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473114A (de) * 1963-08-28 1969-05-31 Merck Ag E Verfahren zur Herstellung von substituierten Flavanoiden
CH471113A (de) * 1965-01-29 1969-04-15 Merck Ag E Verfahren zur Herstellung von wasserlöslichen Flavanoidderivaten
DE1518015C3 (de) * 1965-04-23 1974-06-06 Merck Patent Gmbh, 6100 Darmstadt Substituierte Flavanderivate sowie Verfahren zu ihrer Herstellung
FR5443M (hu) * 1966-04-26 1967-10-09
IT1134205B (it) * 1980-11-11 1986-08-13 Bonomelli Spa Processo per la produzione di derivati flavonici ad attivita' medicinale
FR2543550B1 (fr) * 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5715780A (en) * 1979-04-10 1980-10-16 F. Hoffmann-La Roche & Co. 3-alkoxy flavone derivatives
AU2087083A (en) * 1982-11-02 1984-05-10 Hokuriku Pharmaceutical Co. Ltd. N-substituted flavone 8-carboxamides

Also Published As

Publication number Publication date
JPS61130284A (ja) 1986-06-18
HUT40098A (en) 1986-11-28
HU194856B (en) 1988-03-28
JPH0749427B2 (ja) 1995-05-31
EP0183169A3 (en) 1987-04-22
DE3570077D1 (en) 1989-06-15
EP0183169A2 (de) 1986-06-04
US4713465A (en) 1987-12-15
ES549255A0 (es) 1987-10-01
AU4988885A (en) 1986-06-05
US4788215A (en) 1988-11-29
EP0183169B1 (de) 1989-05-10
ES8708220A1 (es) 1987-10-01
DE3505611A1 (de) 1986-05-28

Similar Documents

Publication Publication Date Title
AU4568985A (en) Tryptamine-5-methanesulfonamide
AU4401185A (en) Belastungsabhangig frequenzvariabler herzschrittmacher
AU4222285A (en) Pyrrolobenzimidazoles
AU3839785A (en) Sammelpackung
AU4254685A (en) Arylhydroxamates
AU4256585A (en) 1-heteroaryl-4-aryl-pyrazolin-5-ones
AU3749685A (en) Induktionsmotor
AU4105285A (en) Tetrahydrofuran-2-ylmethylamines
AU4061285A (en) Schaltersicherungseinheit
AU586649B2 (en) Halogenohydroxyflavones
AU4118385A (en) Verbindungselement
AU4299085A (en) Medizinisches schwingbett
AU4422985A (en) Leucotriene-antagonistic thioethehers
AU4542985A (en) Linear-antriebsvorrichtung
AU4459585A (en) Morpholinols
AU4541685A (en) Bandspanne
AU4544085A (en) Fiberdoseringsanordning
AU4357485A (en) Injektionsspritze
AU4271085A (en) Metallophosphoaluminates
AU4603785A (en) Mulltransportfahrzeug
AU4061585A (en) Automatisk fadolsaftapningsanlaeg
AU4216685A (en) Aminocarnitines
AU4501885A (en) Gudgeon-pin
AU4356785A (en) Reinigungsburste
AU4491785A (en) Dehorner